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Abstract
Background: New Zealand has relatively high rates of morbidity and mortality from infectious disease compared
with other OECD countries, with infectious disease being more prevalent in children compared with others in the
population. Consequences of infectious disease in children may have significant economic and social impact
beyond the direct effects of the disease on the health of the child; including absence from school, transmission of
infectious disease to other pupils, staff, and family members, and time off work for parents/guardians. Reduction of
the transmission of infectious disease between children at schools could be an effective way of reducing the
community incidence of infectious disease. Alcohol based no-rinse hand sanitisers provide an alternative hand
cleaning technology, for which there is some evidence that they may be effective in achieving this. However, very
few studies have investigated the effectiveness of hand sanitisers, and importantly, the potential wider economic
implications of this intervention have not been established.
Aims: The primary objective of this trial is to establish if the provision of hand sanitisers in primary schools in the
South Island of New Zealand, in addition to an education session on hand hygiene, reduces the incidence rate of
absence episodes due to illness in children. In addition, the trial will establish the cost-effectiveness and conduct a
cost-benefit analysis of the intervention in this setting.
Methods/Design: A cluster randomised controlled trial will be undertaken to establish the effectiveness and cost-
effectiveness of hand sanitisers. Sixty-eight primary schools will be recruited from three regions in the South Island
of New Zealand. The schools will be randomised, within region, to receive hand sanitisers and an education
session on hand hygiene, or an education session on hand hygiene alone. Fifty pupils from each school in years 1
to 6 (generally aged from 5 to 11 years) will be randomly selected for detailed follow-up about their illness
absences, providing a total of 3400 pupils. In addition, absence information will be collected on all children from
the school rolls. Investigators not involved in the running of the trial, outcome assessors, and the statistician will be
blinded to the group allocation until the analysis is completed.
Trial registration: ACTRN12609000478213
Background
New Zealand (NZ) has relatively high rates of morbidity
and mortality from infectious disease compared with
other OECD countries, with infectious diseases, predo-
minantly acute respiratory infections, accounting for
12% of admissions to NZ hospitals [1]. Children, the
elderly, and socially disadvantaged groups are known to
be at higher risk of infectious disease than others in the
population.
One of the important consequences of illness in school
aged children is absence from school. Although short
absences are unlikely to have any long term effect on
children’s learning, they are disruptive for the child, their
family, and the class. However, infectious illnesses in
school children have a number of effects in addition to
the direct effects of the disease on the sick child’s well-
being. Transmission from an infected child to other
pupils, staff, and family members affects their wellbeing
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affected. In addition, when a child needs to stay at home
because of illness, caregivers who are in paid work may
need to take time off work or pay for care of the child at
home. Therefore, childhood infectious diseases may have
a significant economic and social impact on the commu-
nity. However, this has not been well measured.
Reduction of infectious disease requires interruption
of person to person transmission. The opportunities for
transmission of infectious diseases offered by the school
environment are likely to be an important contributor
to the rates of infectious illness experienced by children.
Given that it is not feasible to require all infectious chil-
dren to stay away from school (because of asymptomatic
transmission, high incidence, and often mild symptoms),
reduction of transmission between children at school
could be an effective way of reducing the incidence of
infectious disease. A 2002 review concluded that “the
weight of evidence suggests that personal and environ-
mental hygiene reduces the spread of infection” [2].
There are a number of studies that have assessed the
impact of improving hand hygiene to reduce infectious
disease incidence in homes [3-6], childcare centres [7,8],
University halls of residence [9], and primary schools
[10-13]. Meta-analyses have found that handwashing
reduces diarrhoea by approximately one third [14,15]
and respiratory infection by approximately 20% [14,16].
A recent randomised controlled trial in China [10]
found a 42% reduction (p = 0.03) in school absence
among children attending schools that were given a
handwashing promotion programme and supplied with
soap. In developed countries, soap, water, and drying
facilities are frequently provided in schools; compliance
with hand washing and drying has not been reported
but is likely to be poor based on observational studies of
older students [17].
Alcohol-based no-rinse hand sanitiser is an alternative
hand cleaning technology, which requires only the liquid
and a dispenser, no drying facilities, and needs mini-
mum maintenance (refilling the dispenser as required).
A recent meta-analysis of hand hygiene interventions in
a range of community settings found that hand saniti-
sers reduced the rate of gastrointestinal illness and of
‘combined illnesses’ (e.g. school absences), but that there
were very few studies and further, definitive studies are
still required [14]. Importantly, no information was pro-
vided on the potential cost-effectiveness of the
intervention.
Trial objectives
The primary objective of the trial is to establish if the
provision of hand sanitisers in primary schools in the
South Island of NZ, in addition to an education session
on hand hygiene, reduces the incidence rate of absence
episodes due to illness in children. Secondary objectives
include whether hand sanitisers are effective in reducing
the (i) incidence rate of respiratory illness absence epi-
sodes, (ii) incidence rate of gastrointestinal illness
absence episodes, (iii) average length of illness episode,
(iv) incidence rate of absence for any reason, (iv) average
length of absence episode, (v) average number of house-
hold members who become ill within one week of the
participating child’s illness onset. We will examine if the
intervention is associated with any skin reactions. We
will also undertake a cost-effectiveness analysis, provid-
ing incremental cost-effectiveness ratios for the cost per
absence episode due to illness avoided, the cost per
absence attributable to illness, and the cost per days of
work lost for parents/guardians (hereafter referred to as
parents). We will also conduct a cost-benefit analysis,
with the benefits being measured using parents’ reported
willingness-to-pay (WTP).
Methods/Design
Trial design
The design of the trial will be a cluster randomised con-
trolled trial (C-RCT). While this design is less efficient
compared to an individually RCT, and will therefore
require more children, it has been chosen for several
reasons. This design will reduce contamination which
would be likely to occur if students within the same
school were allocated to both the hand sanitiser and
standard hand washing interventions. Second, this
design evaluates the effectiveness of how the interven-
tion would be implemented in practice; with hand sani-
tisers installed in schools. The effectiveness of the
intervention may vary if only some children within
schools used the hand sanitiser compared to all chil-
dren, because of the communicable nature of infectious
diseases (’herd-effect’). Finally, it is more feasible to run
the trial as a cluster trial since it involves less work for
the teachers. As a C-RCT, teachers do not have to
monitor which children use the hand sanitisers, as they
would in an individually RCT.
A random selection of 50 children per school will be
selected for whom detailed information about their ill-
ness absences will be sought from their parents. These
children are referred hereafter as the ‘follow-up chil-
dren’. In addition to the ‘follow-up children’,a b s e n c e
information will be collected on all children, from the
school rolls (Figure 1).
Eligibility and recruitment
Recruitment of schools
A list of all primary schools will be obtained from the NZ
Ministry of Education in September 2008. This list will
include the total school roll size. Where the school has
pupils in years 7 and 8, the school will be contacted to
find out the number of pupils in years 1 to 6. Principals of
all primary schools in Christchurch City, Dunedin City,
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Figure 1 Flow diagram of the progress of schools and children through the trial.
1 Includes all children in school years 1 to 6 (generally
aged from five to eleven).
2 ’Follow-up children’ are a randomly selected sample of “All children”, whose parents are followed up for detailed
information about their illness absences. The primary outcome, absence episodes due to illness, is only measured on this group of children.
Figure adapted from Campbell [30].
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than 100 children in years 1 to 6, will be approached by
letter during the last term of 2008, asked to confirm that
they currently have at least 100 year 1 to 6 pupils, invited
to participate, and asked to respond on a ‘fax back’ form.
Study staff will explain the study procedures further by tel-
ephone or in person, as requested. Schools that do not
return their fax back form will be contacted by telephone
t oa s kt h e mt od os o .
We will follow each school’s usual procedures for
deciding whether the school will be part of the study. For
example, this may involve the principal gaining approval
from the Board of Trustees; a group of elected people
who are responsible for the governance, control, and
management of the school. Based on recent experience
from a study of gastrointestinal illness involving NZ pri-
mary schools, we estimate that approximately 50% of
schools will agree to participate (A. Ball, personal
communication).
Recruitment of follow-up children
In each school, 50 children will be randomly selected
from the school roll in February 2009 by a school liaison
research assistant. For each school, a list of numbers
between 1 and the total number of children in years 1 to
6 in that school will be randomly sorted. The school liai-
son research assistant will know what intervention group
the school has been assigned to, but will be provided
only with the first 50 numbers from the randomly sorted
list and a printout of the current school roll by the school
administrative staff. They will number the children on
the list from 1 to the maximum number, and identify the
children whose numbers correspond with the random
numbers they have been provided with. They will record
the name and class number of those children. The
selected children’s parents will be contacted by a letter
and information sheet sent home via their child, to seek
consent for follow-up, should those children be absent
from school during terms 2 and 3.
Inclusion criteria
Schools will be included if the following criteria are met:
1) There are at least 100 children of primary school
age (school years 1 to 6; children will generally range in
age from five to eleven years) at November 2008.
2) Schools are currently not using hand sanitiser pro-
ducts or are willing to not use hand sanitiser products
for the period of the trial if they are randomised to the
control group.
3) Schools are within the city boundaries of Christch-
urch, Dunedin, or Invercargill in NZ.
4) The principal of the school provides written con-
sent for the school to participate in the trial, be rando-
mised, and potentially receive the hand sanitisers.
Follow-up children will be included if the following
criteria are met:
1) Their parents are able to read and understand spo-
ken English to a level where they can read the study
information sheet, complete the consent form, and
respond to telephone interviews. This will be assessed
from a question on the consent form.
2) They attend a year 1 to 6 class in one of the
included schools, at the beginning of the second school
term in 2009 (the end of April).
Exclusion criteria
Schools will be excluded if they are a special needs
school.
Follow-up children will be excluded if they meet the
following criteria:
1) Their parents are principal investigators or study
personnel of the trial.
2) The principal of the primary school directs us not
to approach their family.
Randomisation and allocation concealment
Schools meeting the inclusion criteria will be randomly
allocated, within stratum, to receive either the intervention
or control. Within each stratum, half the schools will be
allocated to the intervention group, and half to the control
group. Three strata will be defined by geographical area
(Canterbury, Otago, and Southland). Geographical area
has been chosen as a stratification variable since we believe
this could be strongly predictive of infectious disease if, for
example, a flu or gastrointestinal illness affected only
selective areas. Consideration was also given to the inclu-
sion of school roll size as a stratification variable since
cluster size is fairly commonly used as a stratification vari-
able [18], potentially predictive of absence due to illness,
and easily measured. However, an analysis of absence data
collected from 12 primary schools in Dunedin over 20
weeks in 2007 revealed no statistically, or clinically, signifi-
cant association between roll size and absence rate.
Two common methods for implementing restricted
randomisation are stratification and matched pairs
designs. We have chosen to use stratification in prefer-
ence to a matched pairs design since the latter design
has important limitations. In this C-RCT there are a
large number of clusters (68), potentially making it diffi-
cult to find matching variables which will form distinct
pairs. In addition, if a school opts out of the trial, the
entire stratum is removed, resulting in a loss of power
[18]. Finally, we wish to be able to calculate estimates of
intra-cluster correlation (ICC) for interpretation of the
results in this study and for providing estimates for the
design of future trials. While this calculation is straight-
forward when stratification is employed, it is more diffi-
cult to estimate when a matched pairs design is used.
Certain assumptions, some of which are untestable, have
to be assumed for a matched pairs design [19].
The trial statistician (JM) will implement the randomi-
sation. She will only be provided with school codes and
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“B”,s oa st or e m a i nb l i n d e dt ot h eg r o u pa l l o c a t i o n .
Stata/MP 10.1 for Windows [20] will be used to gener-
ate the random numbers. PP will randomly allocate “A”
and “B” to the intervention and control, prior to receiv-
ing the allocation list. Randomisation of all the schools
will be undertaken at one time.
Blinding
It is not possible to blind the children, school administra-
tive staff, or the school liaison research assistants. How-
ever, the investigators not involved in the running of the
trial (JM, RA, MP, CB), outcome assessors, and statisti-
cian (JM) will be blinded until the analysis is completed.
Interventions
Control group
During term 1 2009 (March and April 2009), control
schools will have an in-class session, led by the school
liaison research assistant, to discuss hand hygiene. The
content was developed in collaboration with Public
Health Nurses in Dunedin, who have in previous years
had a rolling programme of hand hygiene education in
schools. The session covers the reasons why and when
hand hygiene is important and hand washing technique,
including a demonstration of the importance of thor-
ough washing using an ultra-violet light-sensitive cream,
Glo Germ™. The same session will be used for the inter-
vention group, with the addition of a discussion about
the hand sanitiser. The purpose of this session is to
ensure that the two groups are equivalent with respect
to hand hygiene knowledge (or at least having had the
opportunity to acquire hand hygiene knowledge) at the
beginning of the study. The content of the hand hygiene
education sessions is available in Additional files 1, 2, 3
(Hand hygiene education session: years 1 and 2; Hand
hygiene education session: years 3 and 4; Hand hygiene
education session: years 5 and 6).
Intervention group
Intervention schools will have the in-class session
described above to discuss hand hygiene and to be
instructed in the use of the hand sanitiser during term
1, 2009 (March and April 2009). No-touch dispensers
will be fitted in all classrooms during the first school
holidays in 2009 (April 2009). The hand sanitiser will be
at least 60% alcohol.
Children will be able to use the sanitiser at any time they
wish, but teachers will be asked to ensure that the children
use the hand sanitiser after coughing/sneezing/blowing
their nose, and as they leave for morning break and for the
lunch break. These times have been chosen for two rea-
sons. First, this will allow the slightly unpleasant smell of
the sanitiser (following use by the whole class) to disperse
before the children return to the classrooms. Second,
break times are when transmission is likely to be higher
from children touching one another.
The hand sanitisers will be placed in classrooms to
ensure that there will be some teacher oversight of their
use, minimising the chances of children playing with the
dispensers and sanitiser, and of children getting squirted
in the eyes or mouth.
Timing of recruitment, intervention, and follow-up
School principals will be contacted for potential inclu-
sion in the trial in November 2008. Parents of randomly
selected children will be mailed an information sheet
and consent form during term 1, March 2009, to seek
consent to participate in post-absence interviews.
A l ls c h o o l sw i l lb eg i v e nas i n g l eh e a l t he d u c a t i o ns e s s i o n
on hand hygiene during term 1, (March and April) 2009.
Hand sanitisers will be present in the intervention schools
during terms 2 and 3, 27 April to 25 September 2009.
Absence information will be collected for a total of
twenty school weeks from the first week of term 2, 27
April 2009. Research assistants will collect absence
information from each school weekly. Parents of ran-
domly selected children who have consented to partici-
pate in the post-absence interviews will be telephoned
eight - nine days after the date of the first day of
absence from school.
Trial outcomes
Primary outcome measure
The primary outcome measure for this trial is the num-
ber of absence episodes due to any illness over 20
weeks; excluding injuries and infestation (head lice and
scabies) (Table 1). Absence due to any illness has been
selected as our primary outcome, in preference to
absences due to infectious illness because of difficulties
in accurately diagnosing the illness through interviews
with the children’s parents. The definition of a new epi-
sode of absence due to illness has been variously defined
between trials. For example, Guinan et al [11] defined a
new episode of absence due to illness as one in which
there was a lapse of at least five days between a previous
period of absence due to illness. Other trials have
defined a new episode of absence due to illness as one
where the child is absent for at least one day in a given
week [10]. We will define a new episode of absence due
to illness as one in which there have been at least three
days with no absences due to illness. So, for example, if
a child is absent from school on Friday, present on
Monday, and absent on Tuesday; this will constitute two
absences. However, if a child is absent from school on a
Tuesday, present on Wednesday, and absent again on
Thursday; this will constitute one absence. While there
is no theoretical justification for any particular definition
for a new episode of absence due to illness, an absence
period of at least three days has the advantage of classi-
fying a child who is absent on a Friday and Monday as
having only one absence episode, and further, this defi-
nition has been used previously [21].
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Secondary outcome measures collected on the ‘follow-
up children’ will include the number of absence episodes
due to respiratory illness, number of absence episodes
due to gastrointestinal illness, length of illness episode,
length of absence episode, and number of household
members who become ill within one week of the partici-
pating child’s illness onset (Table 1). An illness will be
defined as respiratory or gastrointestinal using the defi-
nitions applied in a previous trial [13]. A respiratory ill-
ness will be defined as an acute illness that includes at
least one of the following symptoms: runny nose, stuffy
or blocked nose, cough, fever or chills, sore throat, or
sneezing. A gastrointestinal illness will be defined as an
acute illness that includes at least two watery or much
looser than normal bowel movements and stools over a
24 hour period and/or vomiting. The definition of a
new episode of absence due to either respiratory or gas-
trointestinal illness will be defined in the same way as
for the primary outcome measure. The length of an
absence episode will be defined as the number of days a
child was absent from school for a particular episode.
The length of the illness episode will be defined as the
number of days between the first and last day of
absence. For children who are absent on only a Monday
or only a Friday, we will define the length of the episode
as two days.
Secondary outcome measures collected on all children
from the school roll include the number of absence epi-
sodes and the length of an absence episode.
Adverse events
Following the intervention period, telephone interviews
of parents of the ‘follow-up children’ will be undertaken
to collect information on the presence of any skin reac-
tions which may have occurred during the intervention
period including: dryness, redness, flakiness, itchiness,
eczema, and any other skin reactions.
Data quality assurance
The follow-up survey of parents will be directly entered
into an online program. To enhance the quality of this
data, responses to most of the questions will be entered
using checkboxes. Absence data collected on all children
will be collected weekly by the school liaison research
assistants and returned to the study co-ordinator. The
study co-ordinator will check this data for invalid codes
and dates before adding the data to the database.
Sample size
T h ep r i m a r yo u t c o m ei nt h i sC - R C Ti st h en u m b e ro f
absence episodes due to illness. In the calculation of
sample size for this outcome, adjustment needs to be
Table 1 Outcome measures
Outcome Collected by Timing of collection Source
Primary outcome
Number of absence episodes due to any illness
1,2 Telephone
interview
8 - 9 days after the date of the first day
of absence from school
Parents of
children
Secondary outcomes
’Follow-up children’
Number of absence episodes due to respiratory illness Telephone
interview
8 - 9 days after the date of the first day
of absence from school
Parents of
children
Number of absence episodes due to gastrointestinal illness Telephone
interview
8 - 9 days after the date of the first day
of absence from school
Parents of
children
Length of illness episode Telephone
interview
8 - 9 days after the date of the first day
of absence from school
Parents of
children
Length of absence episode Telephone
interview
8 - 9 days after the date of the first day
of absence from school
Parents of
children
Number of household members who become ill within one week
of the participating child’s illness onset
Telephone
interview
8 - 9 days after the date of the first day
of absence from school
Parents of
children
All children
Number of absence episodes for any reason Liaison research
assistant
3
Weekly School roll
Length of absence episode Liaison research
assistant
3
Weekly School roll
Adverse events
Skin reactions
1 Telephone
interview
Following the intervention period Parents of
children
1 ’Follow-up children’ only.
2 Parents will not be telephoned where it is clear that the child was not unwell (for example, on a holiday, attended a funeral, etc).
3 Through contact with school staff or by extracting the data in person.
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iance inflation factor used to achieve this is determined
from the average cluster size and the Intra-Cluster Cor-
relation (ICC) [22]. A C-RCT investigating the effective-
ness of handwashing promotion in primary school
children in China, estimated an ICC of 0.15 for absence
prevalence (A Bowen, personal communication 10 July
2007). This estimate has been used in the following cal-
culations. We have powered this trial to detect a 20%
reduction in the rate of absence episodes due to illness
between arms. If the rate of absence episodes due to ill-
ness at 20 weeks follow-up is 2.2 episodes per pupil in
the control arm (equivalent to an average of 11 absences
per 100 pupil-weeks; the average of 2006/07 winters in
Otago/Southland), then a sample of 27 schools per arm,
with an average of 50 pupils per school, will be suffi-
cient to detect a 20% reduction in the rate, to 1.76 epi-
sodes per pupil per 20 weeks follow-up, with 80% power
[23]. This assumes a significance level of 5%.
Allowing for 20% attrition in schools, we plan to initi-
ally recruit 34 schools per arm, providing outcome
information on a total of 3400 pupils.
Effectiveness analyses
Analysis subsets
The principal of intention-to-treat (ITT) is the appropri-
ate strategy to be used in the primary analysis of the
data in this C-RCT for two key reasons. It has the
advantage of providing an unbiased estimate of interven-
tion effect because it maintains the balance in prognos-
tic factors between intervention groups, brought about
through randomisation. In addition, it allows for non-
compliance of hand sanitiser use, therefore providing an
estimate of intervention effect which is more reflective
of what would occur should the hand sanitisers be
implemented in schools [24,25].
Requirements of an ideal ITT analysis include full
compliance with the randomised intervention, no miss-
ing responses, and follow-up on all participants [24]. In
a C-RCT, non-adherence to the intervention and loss to
f o l l o w - u pa r em o r ec o m p l e xt h a ni na ni n d i v i d u a l l y
RCT, since these can occur at multiple levels. In this
trial, at the school level, schools in the intervention
group may cease using the hand sanitisers while schools
in the control group may commence using hand saniti-
sers, and in addition, schools may withdraw. At the level
of the child, there will be non-adherence to the inter-
vention, children may move schools, and parents of ‘fol-
low-up children’ may withdraw.
We plan to implement procedures to maintain com-
pliance and minimise loss to follow-up. While we expect
there will be some attrition, we do not expect this to be
large for the primary outcome, or the outcomes
collected on all children. For the former, if we are
unable to contact the parents’ of the ‘follow-up children’
t oa s c e r t a i nw h yt h e yw e r ea b s e n t ,w em a yb ea b l et o
determine the reason for the absence from the school
administrative staff. For the latter, this data will be col-
lected from the school roll where possible. Therefore, as
our primary analysis, we plan to present a modified ITT
analysis, where we will analyse participants as they have
been randomised, regardless of the intervention they
received, but will not impute missing data. As a second
approach, we plan to identify potential predictors of
missingness through modelling, and include these pre-
dictors in the primary analysis model.
A secondary per-protocol analysis will be undertaken
where we will only include schools which complied with
their allocated intervention. For the intervention group,
we will define schools as complying if they used at least
45 ml per child of hand sanitiser solution over the study
period. This usage equates to using the hand sanitiser at
least once per day.
Descriptive analyses at baseline
Descriptive statistics will be presented by intervention
group at baseline to compare the comparability of the
groups and to provide a description of the population.
Summary statistics of demographic and potential con-
founding variables will be presented.
Primary analysis
We will estimate the effectiveness of the hand sanitisers
on the number of absence episodes due to any illness
with marginal modelling using a generalised estimating
equation. This will appropriately account for correlation
that will occur between children within the same school.
We plan to fit an exchangeable correlation structure,
where responses from the same the same school are
assumed to be equally correlated [26]. In addition, we
will use robust variance estimation which will provide
valid standard errors even if the within-school correla-
tion structure has been mis-specified [18]. For this out-
come, a negative binomial distribution and link function
will be used. This model will include the stratification
variable geographical area.
Secondary analyses
We will use generalised estimating equations to estimate
the effectiveness of the hand sanitisers using appropriate
distribution and link functions for the secondary out-
comes. As for the primary analysis, we will fit an
exchangeable correlation structure and use robust var-
iance estimation. All models will include the stratifica-
tion variable.
For both the primary and secondary outcomes, we
plan to also estimate the effectiveness of hand sanitisers
adjusting for the potential confounder, school level
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tus may be associated with illness rates [27]. School
level deprivation will be measured using the ‘decile’
assigned to each school by the Ministry of Education for
funding purposes. It reflects the proportion of students
who live in more deprived communities, using informa-
tion from the Census on household income, occupation,
household crowding, educational qualifications, and
income support.
We plan to make no adjustment for multiple testing.
All tests will be two-sided and carried out at the 5%
level of significance. We will document any changes we
make to the study design or statistical analysis plan, or
both, in the trial report.
Economic evaluation
One of the more challenging aspects of this study is
determining the economic cost associated with chil-
dren’s illness and subsequent absence from school.
Broadly speaking there are two basic approaches we can
take to measuring these costs and we will employ both.
By capturing individuals’ employment circumstances
and the amount of time all family members’ work time
is missed as a result of the illness, we can take a Human
Capital approach to estimating the economic impact of
the children’s illness. While the Human Capital
approach is widely used in economic evaluation, its use
is particularly limited here as families in which no work
time is lost have no cost associated with that illness. As
such, we also adopt a WTP approach, asking parents to
assign a value to the cost of the illness. Following the
techniques described by Liu et al [28], this is done by
asking parents to arrive at a figure that they would be
prepared to pay to purchase a hypothetical medication
that would keep their child from acquiring the same ill-
ness (i.e. same symptoms, severity and duration). The
main advantage of this approach is that it allows respon-
dents to place whatever values they deem appropriate in
terms of inconvenience, lost work time and the pain
and suffering of their children.
There is no clear indication in the literature in terms
of the best approach to be used to arrive at a WTP fig-
ure. To avoid the risk of systematically under or over
estimating WTP, each interviewer is randomly assigned
an approach for each new respondent. The first
approach simply asks the respondent to arrive at a fig-
ure on their own. The second approach starts with very
low values and works upwards in pre-determined incre-
ments. The third approach starts with a very high value
and works downwards in pre-determined increments.
The questioning sequence used is available in Additional
file 4 - Willingness-to-pay questioning sequence.
The analysis will provide a direct comparison between
the Human Capital and the WTP approaches. We will
also decompose the costs across various sub-populations
(i.e. different family structures, ethnic groups, low and
high socio-economic status) to determine the extent to
which the economic effect of children’s illness has a dif-
ferent impact on different types of families, of people
with different levels of extended family support and
across socio-economic groups (measured by income,
education and employment status).
A second objective is to examine the extent to which
WTP is affected by the way the question is asked. We
believe this will make an important methodological con-
tribution in the collection of WTP data.
Publication policy
The principal investigator (PP) will ensure that the
results from this trial are published regardless of the
outcome. Reporting of the trial will adhere to the rele-
vant, and most up-to-date, CONSORT statements at the
time of submission [29-31].
Ethical review
The New Zealand Multi-Region Health and Disability
Ethics Committee provided approval for the trial on 13
March 2009 (MEC/09/01/005).
C-RCTs offer additional ethical complexity compared
to individually randomised participant trials [32-34],
particularly concerning informed consent of individuals.
In this trial, the school principals will act as the “gate-
keepers"; providing written consent for the school to
participate in the trial, be randomised, and potentially
receive the hand sanitisers. Parents of all children in the
schools allocated to the hand sanitiser group will be
contacted with an information sheet explaining the
study and informed that hand sanitisers will be fitted in
each classroom in their child’s school. Parents will be
informed that they can opt their child out of using the
hand sanitiser at any stage throughout the trial. Parents
of the randomly selected sub-sample of children (includ-
ing children in the intervention and control groups) will
be asked to provide written informed consent for the
researchers to conduct post-absence interviews with
them.
Anonymised data on absences from all children will be
collected from the school rolls. Consent for this data
collection will not be obtained from parents. Parents of
the children in the intervention group will be informed
that this data will be colleted, through the information
sheet described above. Parents of the children in the
control group will not be informed of the anonymised
data collection.
List of abbreviations
C-RCT: Cluster randomised controlled trial; ITT: Inten-
tion-to-treat; NZ: New Zealand; OECD: Organisation for
Economic Co-operation and Development; WTP: Will-
ingness-to-pay.
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Page 8 of 10Additional file 1: Hand hygiene education session: years 1 and 2.
This file includes the content of the hand hygiene education session for
children in years 1 and 2 (aged approximately 5 and 6 years). In addition,
it also details the instructions provided for using the hand sanitisers for
children in the intervention group.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1745-6215-11-7-
S1.PDF]
Additional file 2: Hand hygiene education session: years 3 and 4.
This file includes the content of the hand hygiene education session for
children in years 3 and 4 (aged approximately 7 and 8 years). In addition,
it also details the instructions provided for using the hand sanitisers for
children in the intervention group.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1745-6215-11-7-
S2.PDF]
Additional file 3: Hand hygiene education session: years 5 and 6.
This file includes the content of the hand hygiene education session for
children in years 5 and 6 (aged approximately 9 and 10 years). In
addition, it also details the instructions provided for using the hand
sanitisers for children in the intervention group.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1745-6215-11-7-
S3.PDF]
Additional file 4: Willingness-to-pay questioning sequence. Three
questioning approaches to measure a parent’s WTP to purchase a
hypothetical medication that would keep their child from acquiring the
same illness at some point in the future. When interviewers make
contact with a parent one of the three approaches to asking the WTP
question is randomly assigned. The basic question being asked is
whether the approach taking to arrive at a WTP figure is influenced by
whether the interviewer starts at a low value and proceeds upwards;
starts at a high value and proceeds downwards, or asks the respondent
to select a figure without prompting with a starting point.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1745-6215-11-7-
S4.PDF]
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